RxDoctor Payments Data

Duane Jasper, MD

Family Medicine · Independence, IANPI 1326035783

Payments from drug & device makers

$1,803in general payments, 2019–2025

Across 148 payments — averaging $12.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$349
  • Johnson & Johnson$224
  • Amgen$199
  • AstraZeneca$195
  • Pfizer$173
  • Novo Nordisk$137
  • plus $526 from 16 others

What the payments were for

  • Food & beverage$1,798100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,803 in reported general payments places this provider in the 85th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$7,398
Medicare patients
42
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Avonex (4 Pack)Interferon Beta-1a15$127,092
EliquisApixaban122$77,403
XareltoRivaroxaban84$73,929
OzempicSemaglutide64$61,331
JardianceEmpagliflozin43$56,156
Tresiba Flextouch U-100Insulin Degludec40$29,259
InvokanaCanagliflozin16$27,707
FarxigaDapagliflozin Propanediol44$22,674
RybelsusSemaglutide15$21,983
MounjaroTirzepatide20$20,892
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog49$20,720
Tresiba Flextouch U-200Insulin Degludec16$14,960
TrulicityDulaglutide14$13,285
MyrbetriqMirabegron23$13,053
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt12$12,652

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto, Invokana$224$101,636100 claims
Novo NordiskOzempic, Rybelsus$137$83,31479 claims
PfizerEliquis$173$77,403122 claims
Boehringer IngelheimJardiance$74$56,15643 claims
Lilly USA, LLCMounjaro, Trulicity$28$34,17734 claims
AstraZenecaFarxiga$195$22,67444 claims
Astellas Pharma US IncMyrbetriq$44$13,05323 claims
Sanofi-aventis U.S. LLCLantus$26$3,63040 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Independence

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →